Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Eghtesad, Saman ^b,e   Jhunjhunwala, Siddharth ^c,f   Little, Steven R ^b,c,d   Clemens, Paula R ^a,b  

^a Affairs Medical Center   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c University of Pittsburgh   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861155859     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00399     Document Type: Article

References (41)

1. Drousiotou, A. etal. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Genet Test. 2(1), 55-60 (1998).
2. Emery, A. E. Population frequencies ofinherited neuromuscular diseases-aworld survey. Neuromuscul Disord. 1(1), 19-29 (1991).
3. Parsons, E. P., Bradley, D. M. & Clarke, A. J. Newborn screening for Duchenne muscular dystrophy. Arch Dis Child. 88(1),91-92 (2003). (Pubitemid 36098983)
4. Emery, A. E. Dystrophin function. Lancet. 335(8700), 1289 (1990). (Pubitemid 20181840)
5. Hoffman, E. P., Brown, R. H., Jr. & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophylocus. Cell. 51(6), 919-928 (1987).
6. Hoffman, E. P. & Schwartz, L. Dystrophin and disease. Mol Aspects Med. 12(3), 175-194 (1991).
7. Bulfield, G., Siller, W., Wight, P. & Moore, K. X Chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci. 81, 1189-1192 (1984). (Pubitemid 14171480)
8. DelloRusso, C. et al. Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Natl Acad Sci U SA. 99(20), 12979-12984 (2002).
9. Gilbert, R. et al. Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products. Hum Gene Ther. 12(14), 1741-1755 (2001). (Pubitemid 32911640)
10. Alba, R., Bosch, A. & Chillon, M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 12, 18-27 (2005).
11. Jiang, Z., Schiedner, G., Gilchrist, S., Kochanek, S. & Clemens, P. R. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle. Gene Ther. 11(19), 1453-1461 (2007). (Pubitemid 39359436)
12. Eghtesad, S., Jhunjhunwala, S., Little, S. R. & Clemens, P. R. Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle. Mol Med. 17, 917-924 (2011).
13. Hackstein, H. etal. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood. 101(11), 4457-4463 (2003). (Pubitemid 36857814)
14. Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z. & Thomson, A. W. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol. 178(11), 7018-7031 (2007). (Pubitemid 46847428)
15. Gilchrist, S., Ontel, M., Kochanek, S. & Clemens, P. R. Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol Ther. 6(3), 359-368 (2002). (Pubitemid 36305338)
16. Hartigan-O'Conner, D., Kirk, C., Crawford, R., Mule, J. & Chamberlain, J. Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol Ther. 4(6), 525-533 (2001). (Pubitemid 34026867)
17. Wells, D. J., Ferrer, A. & Wells, K. E. Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy. Expert Rev Mol Med. 4(23), 1-23 (2002).
18. Yang, Y., Haecker, S., Su, Q. & Wilson, J. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Human Molecular Genetics. 5(11), 1703-1712 (1996). (Pubitemid 26372405)
19. Ferrer,A.,Wells,K.E. &Wells,D.J. Immuneresponsestodystropin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther. 7(17), 1439-1446 (2000).
20. Almond, P. S. et al. Rapamycin in a porcine renal transplant model. Transplant Proc. 25(1 Pt 1), 716 (1993). (Pubitemid 23082530)
21. Lange,C.M.etal. Increased frequency of regulatory T cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycin. TransplInt. 23(3), 266-276 (2010).
22. Battaglia, M. etal. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes. 55(1), 40-49 (2006). (Pubitemid 43343297)
23. Blazar, B. R., Taylor, P. A., Panoskaltsis-Mortari, A. & Vallera, D. A. Rapamycin inhibits the generation ofgraft-versus-host disease-and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.JImmunol. 160(11), 5355-5365 (1998). (Pubitemid 28267824)
24. Chen, B. J., Morris, R. E. & Chao, N. J. Graft-versus-host disease prevention by rapamycin: cellular mechanisms. Biol Blood Marrow Transplant. 6(5A), 529-536 (2000).
25. Charfi, S. et al. Successful treatment ofpost-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment. Saudi J Kidney Dis Transpl. 18(4), 617-620 (2007).
26. Chen, H., Xu, D., Qi, S., Wu, J., Luo, H. & Daloze, P. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat. Transplantation. 59(8), 1084-1089 (1995).
27. Kerkar, N. et al. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant. 5(5), 1085-1089 (2005). (Pubitemid 40571258)
28. Stepkowski, S. M., Chen, H. F., Wang, M. E., Daloze, P. & Kahan, B. D. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Transplantation. 53(2), 258-264 (1992).
29. Vilquin, J. T., Asselin, I., Guerette, B., Kinoshita, I., Roy, R. & Tremblay, J. P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation. 59(3), 422-426 (1992).
30. Eghtesad, S., Zheng, H., Nakai, H., Epperly, M. W. & Clemens, P. R. Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunity. Gene Ther. 17(9), 1181-1190 (2010).
31. Battaglia, M., Stabilini, A. & Roncarolo, M. G. Rapamycin selectively expands CD4 + CD25 + FoxP3+ regulatory T cells. Blood. 105(12), 4743-4748 (2005). (Pubitemid 40807298)
32. Strauss, L., Whiteside, T. L., Knights, A., Bergmann, C., Knuth, A. & Zippelius, A. Selective Survival of Naturally Occurring Human CD4 + CD25 + Foxp3 + Regulatory T Cells Cultured with Rapamycin. J Immunol. 178(1), 320-329 (2007). (Pubitemid 46033615)
33. Jiang, Z. L. et al. Local High-Capacity Adenovirus-Mediated mCTLA4Ig and mCD40Ig Expression Prolongs Recombinant Gene Expression in Skeletal Muscle. Mol Ther. 3(6), 892-900 (2001).
34. Lu, L. etal. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials. 21(18), 1837-1845 (2000). (Pubitemid 30398502)
35. Lei, L. & Schwendeman, S. P. Mapping neutral microclimate pH in PLGA microspheres.JournalofControlledRelease. 101,163-173 (2005). (Pubitemid 39600980)
36. Hickey, E. W. & Hirshfield, I. N. Low-pH-induced effects on patterns of protein synthesis and on internal pH in Escherichia coli and Salmonella typhimurium. ApplEnviron Microbiol. 56(4),1038-1045 (1990). (Pubitemid 20114461)
37. Hayashi, A. A. & Proud, C. G. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am J Physiol Endocrinol Metab. 292(6), E1647-E1655 (2007). (Pubitemid 47084700)
38. Lawrence, J. C. Jr. mTOR-dependent control ofskeletal muscle protein synthesis. Int J Sport Nutr Exerc Metab. 11 Suppl, S177-S185 (2001). (Pubitemid 33679001)
39. Wang, X. & Proud, C. G. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda). 21, 362-369 (2006). (Pubitemid 44511764)
40. Jhunjhunwala, S., Raimondi, G., Thomson, A. W. & Little, S. R. Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release. 133(3), 191-197 (2009).
41. Jiang, Z., Schiedner, G., van Rooijen, N., Liu, C. C., Kochanek, S. & Clemens, P. R. Sustained Muscle Expression of Dystrophin from a High-Capacity Adenoviral Vector with Systemic Gene Transfer of T Cell Costimulatory Blockade. Mol Ther. 10(4), 688-696 (2004). (Pubitemid 39272858)